Pharmiva is an innovation driven company with a focus on diseases related to women’s health. We develop and market products based on a unique expert knowledge within research and development of medical products aimed for local administration.

Major shareholders

Last update: annual meeting of shareholders 16th June 2020

GÅL Pharma AB (founders and management)12,59%
Indavvio AB (founders and management)12,29%
Venture Holdings AB (founders and management) 7,18%
Prolajm AB (management)6,14%
Other investors ( external shareholders)61,80%